Intuitive Surgical, Inc. (ISRG)

In the past six months, Intuitive Surgical's stock price has been impacted by several events. The stock decreased by 8.57% in the past month and 8.70% over the last 12 months as of April 11, 2026. The company released preliminary fourth-quarter 2025 results on January 14, 2026, followed by the full earnings report on January 22, 2026, reporting strong revenue and procedure growth for Q4 2025, but investors were disappointed by projected slower procedure growth for 2026. A cybersecurity breach disclosed on March 13, 2026, compromised employee data, causing investor anxiety and price drops, coupled with reports of serious injuries linked to ISRG's products.

Intuitive Surgical's revenue model suggests a relatively stable base demand due to recurring revenue from instruments, accessories, and service contracts. The placement of new systems and procedure volumes could be subject to quarterly fluctuations based on hospital budgeting cycles and patient elective surgery scheduling. Historically, April has shown a chance of being a "green month" for ISRG stock, which might suggest some seasonal patterns in investor sentiment or market activity around that time.

Intuitive Surgical, Inc. is a biotechnology company that develops, manufactures, and markets robotic products, including the da Vinci Surgical System and the Ion endoluminal system. The da Vinci system enables surgeons to perform complex procedures with enhanced precision across various surgical specialties. The company's business model relies on recurring revenue from instruments, accessories, and service contracts.

Intuitive Surgical is headquartered in Sunnyvale, California, and has a global presence in over 70 countries. North America is its largest market, with a growing presence in Europe and the Asia-Pacific region. The company has a robust distribution network with offices and manufacturing facilities in various locations, including Mexicali, Mexico.

Intuitive Surgical's brand reputation has faced challenges due to a cybersecurity breach and reports of injuries associated with its products. Despite these events, the company is generally viewed as a leading supplier in the surgical robotics market, recognized for its focus on advancing minimally invasive care. The company's long-term performance contributes to a generally positive underlying perception.

Intuitive Surgical, Inc. is heavily dominated by institutional owners, who collectively hold approximately 85% of the company's shares. Major institutional shareholders include Vanguard Group Inc., BlackRock, Inc., and State Street Corp. Individual investors hold around 14% of the company, while insiders own less than 1% of the company's shares.